Product logins

Find logins to all Clarivate products below.


Regina Galera

Director, Regulatory and Clinical Consulting, Life Sciences and Healthcare

Regina is a MSc Industrial Pharmacist by the University of Barcelona with over 19 years of experience in the Pharmaceutical and Medical Device Industry. She is a seasoned professional within the Regulatory, Clinical, Quality and Vigilance fields across EMEA, North America, Latin America, Asia Pacific and Japanese markets.

She has experience both in Industry with international companies such as Alcon (Novartis), Smith & Nephew and Olympus as well as in Consulting (IQVIA) interacting with Competent Authorities, Notified Bodies, Certification Bodies and Third-party auditors. Among others, she has worked with ophthalmic drugs, antibiotics, anesthetics, aesthetic products, combination products, class I-III medical devices, including implantable, custom-made, active and software as a medical device (SaMD).

She leads a team of experienced consultants who are focused on developing strategic technology enabled customized Regulatory and Clinical solutions with a holistic approach for Pharmaceuticals, Biologics, Medical Devices, Combination products and Consumer Health covering more than 140 countries.


arrow_forward
Get in touch with Regina

Latest news

Partner news August 17, 2026
ShanghaiRanking’s Academic Ranking of World Universities 2026 Press Release

The 2026 Academic Ranking of World Universities (ARWU) is released today by ShanghaiRanking Consultancy. Since 2003, ARWU has been presenting the world’s top universities annually based on transparent methodology and…

Partner news
News August 13, 2026
Clarivate and KYBORA Partner to Help Biopharma Companies Execute Strategic Transaction Outcomes

This collaboration combines the scientific and commercial expertise of Clarivate’s Life Sciences & Healthcare Consulting practice with KYBORA’s global transaction execution capabilities to accelerate life sciences transactions London, U.K., August…

News August 12, 2026
Clarivate Enhances SkyRiver to Help Libraries Share, Reuse and Create Trusted Metadata

Combining community metadata sharing, institutional choice and AI-powered record creation LONDON, UK, August 12, 2026 – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the…

Related resources

Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials CMC Development R&D Real-World Data Regulatory Research Safety
Three uncomfortable truths about cell and gene therapy in regulatory affairs Three uncomfortable truths about cell and gene therapy in regulatory affairs
Blog May 28, 2026
Three uncomfortable truths about cell and gene therapy in regulatory affairs
Consulting Resource Center Regulatory
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.